var singsData = [{"date":new Date(2012,10,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,10,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2012,10,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2012,10,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,8),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,10,8),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,10,8),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2012,11,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs downgrades CME to Sell from Neutral. Target Price is $48.","showOnAxis":true},{"date":new Date(2012,11,13),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.3","showOnAxis":true},{"date":new Date(2012,11,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods downgrades CME to Underperform from Market Perform.","showOnAxis":true},{"date":new Date(2012,11,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45","showOnAxis":true},{"date":new Date(2012,11,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,11,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,2,12),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,2,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Hold. Target Price is $280; previously $275.","showOnAxis":true},{"date":new Date(2012,2,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus maintains CME to Buy. Target Price is $320; previously $295.","showOnAxis":true},{"date":new Date(2012,2,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CME to Buy. Target Price is $330; previously $311.","showOnAxis":true},{"date":new Date(2012,2,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Evercore Partners maintains CME to Equal-Weight. Target Price is $285; previously $250.","showOnAxis":true},{"date":new Date(2012,2,7),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $1.046","showOnAxis":true},{"date":new Date(2012,3,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Indaba Global Research initiates coverage on CME to Sell. Target Price is $222.","showOnAxis":true},{"date":new Date(2012,3,18),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,3,18),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,3,26),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,3,26),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,3,26),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CME reports 2012 Q1's earning $0.8 per share and revenue $745.5MM..","showOnAxis":false},{"date":new Date(2012,3,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"ISI Group maintains CME to Hold. Target Price is $275; previously $285.","showOnAxis":true},{"date":new Date(2012,3,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Neutral. Target Price is $263; previously $270.","showOnAxis":true},{"date":new Date(2012,3,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CME to Buy. Target Price is $300; previously $325.","showOnAxis":true},{"date":new Date(2012,3,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CME to Buy. Target Price is $300; previously $330.","showOnAxis":true},{"date":new Date(2012,3,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Hold. Target Price is $300; previously $280.","showOnAxis":true},{"date":new Date(2012,3,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CME to Buy. Target Price is $325; previously $305.","showOnAxis":true},{"date":new Date(2012,4,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2012,4,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2012,4,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,4,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,4,24),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,4,24),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2012,5,13),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2012,5,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BGB Securities initiates coverage on CME to Hold.","showOnAxis":true},{"date":new Date(2012,5,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,5,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,5,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.446","showOnAxis":true},{"date":new Date(2012,6,26),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,6,26),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,6,26),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CME reports 2012 Q2's earning $0.74 per share and revenue $767MM..","showOnAxis":false},{"date":new Date(2012,7,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CME to Neutral. Target Price is $104; previously $101.","showOnAxis":true},{"date":new Date(2012,8,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan downgrades CME to Underweight from Neutral. Target Price is $54; previously $56.5.","showOnAxis":true},{"date":new Date(2012,8,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,8,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2012,8,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2012,8,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2012,8,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2012,8,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45","showOnAxis":true},{"date":new Date(2012,9,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CME to Buy. Target Price is $65; previously $60.","showOnAxis":true},{"date":new Date(2012,9,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs assumes CME to Neutral. Target Price is $53.","showOnAxis":true},{"date":new Date(2012,9,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CME reports 2012 Q3's earning $0.66 per share and revenue $653MM..","showOnAxis":false},{"date":new Date(2012,9,26),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Raymond James upgrades CME to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2012,9,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BGB Securities maintains CME to Hold. Target Price is $54; previously $57.","showOnAxis":true},{"date":new Date(2012,9,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Evercore Partners downgrades CME to Equal-Weight from Overweight.","showOnAxis":true},{"date":new Date(2012,9,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CME to Buy. Target Price is $64; previously $66.","showOnAxis":true},{"date":new Date(2012,9,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Underweight. Target Price is $55; previously $54.","showOnAxis":true},{"date":new Date(2012,9,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Stifel Nicolaus downgrades CME to Hold from Buy.","showOnAxis":true},{"date":new Date(2013,0,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Compass Point initiates coverage on CME to Neutral. Target Price is $55.","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America assumes CME to Neutral.","showOnAxis":true},{"date":new Date(2013,1,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America assumes CME to Neutral. Target Price is $60.","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,1,5),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, CME reports 2012 Q4's earning $0.63 per share and revenue $660.9MM. This misses analyst's estimated EPS $0.64, misses estimated revenue $664.16MM.","showOnAxis":false},{"date":new Date(2013,10,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,10,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,10,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,10,7),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2013,11,24),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $2.6","showOnAxis":true},{"date":new Date(2013,11,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45","showOnAxis":true},{"date":new Date(2013,2,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Underweight. Target Price is $53; previously $51.","showOnAxis":true},{"date":new Date(2013,2,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45","showOnAxis":true},{"date":new Date(2013,3,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CME to Buy. Target Price is $69; previously $65.","showOnAxis":true},{"date":new Date(2013,3,17),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2013,3,17),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,3,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse downgrades CME to Neutral from Overweight. Target Price is $58.","showOnAxis":true},{"date":new Date(2013,4,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,4,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,4,2),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CME reports 2013 Q1's earning $0.73 per share and revenue $718.6MM. This meets analyst's estimated EPS $0.73, beats estimated revenue $711.88MM.","showOnAxis":false},{"date":new Date(2013,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie downgrades CME to Neutral from Outperform. Target Price is $60; previously $69.","showOnAxis":true},{"date":new Date(2013,4,22),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,4,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Compass Point maintains CME to Neutral. Target Price is $60; previously $55.","showOnAxis":true},{"date":new Date(2013,4,31),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Keefe Bruyette & Woods upgrades CME to Market Perform from Underperform.","showOnAxis":false},{"date":new Date(2013,5,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2013,5,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"ISI Group upgrades CME to Buy from Neutral. Target Price is $80; previously $70.","showOnAxis":false},{"date":new Date(2013,5,24),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades CME to Neutral from Sell.","showOnAxis":false},{"date":new Date(2013,5,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"JP Morgan upgrades CME to Neutral from Underweight. Target Price is $72; previously $52.5.","showOnAxis":false},{"date":new Date(2013,5,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CME to Buy. Target Price is $78; previously $69.","showOnAxis":true},{"date":new Date(2013,5,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Wells Fargo upgrades CME to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2013,5,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45","showOnAxis":true},{"date":new Date(2013,6,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Raymond James downgrades CME to Market Perform from Outperform; previously $72.","showOnAxis":true},{"date":new Date(2013,7,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,7,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2013,7,1),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CME reports 2013 Q2's earning $0.93 per share and revenue $816.1MM. This beats analyst's estimated EPS $0.88, beats estimated revenue $803.79MM.","showOnAxis":false},{"date":new Date(2013,7,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CME to Buy. Target Price is $83; previously $84.","showOnAxis":true},{"date":new Date(2013,8,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Keefe Bruyette & Woods upgrades CME to Outperform from Market Perform. Target Price is $89; previously $81.","showOnAxis":false},{"date":new Date(2013,8,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2013,8,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2013,8,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2013,8,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.45","showOnAxis":true},{"date":new Date(2013,9,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Compass Point maintains CME to Neutral. Target Price is $75; previously $70.","showOnAxis":true},{"date":new Date(2014,0,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Neutral. Target Price is $76.5; previously $75.5.","showOnAxis":true},{"date":new Date(2014,0,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup downgrades CME to Neutral from Buy. Target Price is $82.","showOnAxis":true},{"date":new Date(2014,1,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,1,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,1,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,1,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,10,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,10,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2014,11,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,11,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $98; previously $96.","showOnAxis":true},{"date":new Date(2014,11,2),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,11,24),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $2","showOnAxis":true},{"date":new Date(2014,11,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47","showOnAxis":true},{"date":new Date(2014,11,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe, Bruyette & Woods downgrades CME to Market Perform from Outperform. Target Price is $92.","showOnAxis":true},{"date":new Date(2014,2,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Compass Point terminates CME coverage  from Neutral; previously $75.","showOnAxis":true},{"date":new Date(2014,2,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47","showOnAxis":true},{"date":new Date(2014,3,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CME to Neutral. Target Price is $74; previously $78.","showOnAxis":true},{"date":new Date(2014,3,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CME to Neutral. Target Price is $74; previously $78.","showOnAxis":true},{"date":new Date(2014,4,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,1),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,4,14),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $78; previously $82.","showOnAxis":true},{"date":new Date(2014,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CME to Hold. Target Price is $73; previously $74.","showOnAxis":true},{"date":new Date(2014,4,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CME to Buy. Target Price is $79; previously $83.","showOnAxis":true},{"date":new Date(2014,4,20),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,4,21),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2014,4,21),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,4,21),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2014,4,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Neutral. Target Price is $69.5; previously $76.5.","showOnAxis":true},{"date":new Date(2014,4,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CME to Buy. Target Price is $84; previously $89.","showOnAxis":true},{"date":new Date(2014,5,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Neutral. Target Price is $67.5; previously $69.5.","showOnAxis":true},{"date":new Date(2014,5,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $77; previously $75.","showOnAxis":true},{"date":new Date(2014,5,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47","showOnAxis":true},{"date":new Date(2014,6,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,6,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,6,31),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,6,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Neutral. Target Price is $68; previously $67.5.","showOnAxis":true},{"date":new Date(2014,7,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $75; previously $76.","showOnAxis":true},{"date":new Date(2014,7,25),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,7,25),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,8,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,8,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,8,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank initiates coverage on CME to Buy. Target Price is $85.","showOnAxis":true},{"date":new Date(2014,8,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains CME to Outperform. Target Price is $90; previously $80.","showOnAxis":true},{"date":new Date(2014,8,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2014,8,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,8,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.47","showOnAxis":true},{"date":new Date(2014,9,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $96; previously $95.","showOnAxis":true},{"date":new Date(2014,9,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CME to Neutral. Target Price is $83; previously $74.","showOnAxis":true},{"date":new Date(2014,9,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2014,9,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2014,9,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CME to Neutral. Target Price is $84; previously $82.","showOnAxis":true},{"date":new Date(2014,9,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CME to Neutral. Target Price is $82; previously $73.","showOnAxis":true},{"date":new Date(2014,9,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bank of America maintains CME to Neutral. Target Price is $82; previously $76.","showOnAxis":true},{"date":new Date(2015,0,15),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,0,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Citigroup upgrades CME to Buy from Neutral. Target Price is $94; previously $88.","showOnAxis":false},{"date":new Date(2015,0,20),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,0,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,0,23),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,0,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $102; previously $101.","showOnAxis":true},{"date":new Date(2015,0,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"CLSA downgrades CME to Underperform from Outperform.","showOnAxis":true},{"date":new Date(2015,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CME to Buy. Target Price is $97; previously $93.","showOnAxis":true},{"date":new Date(2015,1,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,1,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,1,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,1,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains CME to Buy. Target Price is $100; previously $94.","showOnAxis":true},{"date":new Date(2015,1,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $104; previously $102.","showOnAxis":true},{"date":new Date(2015,10,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,10,11),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,10,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,10,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2015,11,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $2.9","showOnAxis":true},{"date":new Date(2015,11,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.5","showOnAxis":true},{"date":new Date(2015,11,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital initiates coverage on CME to Underperform. Target Price is $83.","showOnAxis":true},{"date":new Date(2015,2,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,2,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2015,2,19),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Termination of a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,2,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CME to Buy. Target Price is $104; previously $97.","showOnAxis":true},{"date":new Date(2015,2,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2015,2,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,2,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2015,2,4),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Other 8-K Events\r\n","showOnAxis":true},{"date":new Date(2015,2,6),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.5","showOnAxis":true},{"date":new Date(2015,2,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $106; previously $104.","showOnAxis":true},{"date":new Date(2015,3,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $90; previously $91.","showOnAxis":true},{"date":new Date(2015,3,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,3,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,4,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $89; previously $90.","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,4,20),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2015,4,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2015,4,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Evercore ISI Group upgrades CME to Buy from Hold.","showOnAxis":false},{"date":new Date(2015,4,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $87; previously $89.","showOnAxis":true},{"date":new Date(2015,4,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $105; previously $104.","showOnAxis":true},{"date":new Date(2015,5,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $98; previously $92.","showOnAxis":true},{"date":new Date(2015,5,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Neutral. Target Price is $92; previously $93.","showOnAxis":true},{"date":new Date(2015,5,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.5","showOnAxis":true},{"date":new Date(2015,6,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $96; previously $87.","showOnAxis":true},{"date":new Date(2015,6,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,6,30),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,6,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $102; previously $100.","showOnAxis":true},{"date":new Date(2015,6,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CME to Buy. Target Price is $108; previously $105.","showOnAxis":true},{"date":new Date(2015,7,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $100; previously $96.","showOnAxis":true},{"date":new Date(2015,8,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Neutral. Target Price is $97; previously $99.","showOnAxis":true},{"date":new Date(2015,8,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.5","showOnAxis":true},{"date":new Date(2015,9,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2015,9,29),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2015,9,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $98; previously $100.","showOnAxis":true},{"date":new Date(2015,9,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $98; previously $102.","showOnAxis":true},{"date":new Date(2016,0,13),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"JP Morgan upgrades CME to Overweight from Neutral.","showOnAxis":false},{"date":new Date(2016,0,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $105; previously $104.","showOnAxis":true},{"date":new Date(2016,0,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains CME to Neutral. Target Price is $100; previously $94.","showOnAxis":true},{"date":new Date(2016,1,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,1,5),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,1,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $97; previously $100.","showOnAxis":true},{"date":new Date(2016,1,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $110; previously $106.","showOnAxis":true},{"date":new Date(2016,10,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,10,10),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan downgrades CME to Neutral from Overweight.","showOnAxis":true},{"date":new Date(2016,10,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Entry into a Material Definitive Agreement\r\n","showOnAxis":true},{"date":new Date(2016,10,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,10,3),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Issue new debts or other obligations.\r\n","showOnAxis":true},{"date":new Date(2016,11,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $3.25","showOnAxis":true},{"date":new Date(2016,11,7),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.6","showOnAxis":true},{"date":new Date(2016,2,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Neutral. Target Price is $2.78; previously $2.63.","showOnAxis":true},{"date":new Date(2016,2,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.6","showOnAxis":true},{"date":new Date(2016,3,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,3,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,3,28),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CME reports 2016 Q1's earning $1.15 per share and revenue $934.2MM. This meets analyst's estimated EPS $1.15, misses estimated revenue $942.43MM.","showOnAxis":false},{"date":new Date(2016,3,6),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Change of exectives and board members.\r\n","showOnAxis":true},{"date":new Date(2016,3,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $98; previously $97.","showOnAxis":true},{"date":new Date(2016,4,18),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Submission of Matters to a Vote of Security Holders\r\n","showOnAxis":true},{"date":new Date(2016,4,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Sterne Agee CRT initiates coverage on CME to Neutral. Target Price is $90.","showOnAxis":true},{"date":new Date(2016,4,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Buckingham Research initiates coverage on CME to Buy. Target Price is $105.","showOnAxis":true},{"date":new Date(2016,5,8),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.6","showOnAxis":true},{"date":new Date(2016,6,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"CLSA maintains CME to Underperform. Target Price is $100; previously $95.","showOnAxis":true},{"date":new Date(2016,6,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,6,28),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,6,28),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CME reports 2016 Q2's earning $1.14 per share and revenue $906.4MM. This beats analyst's estimated EPS $1.11, misses estimated revenue $912.29MM.","showOnAxis":false},{"date":new Date(2016,6,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains CME to Equal-Weight. Target Price is $100; previously $99.","showOnAxis":true},{"date":new Date(2016,6,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $111; previously $110.","showOnAxis":true},{"date":new Date(2016,6,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains CME to Overweight. Target Price is $106; previously $99.","showOnAxis":true},{"date":new Date(2016,6,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains CME to Market Perform. Target Price is $103; previously $99.","showOnAxis":true},{"date":new Date(2016,6,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains CME to Buy. Target Price is $114; previously $104.","showOnAxis":true},{"date":new Date(2016,7,31),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains CME to Buy. Target Price is $118; previously $112.","showOnAxis":true},{"date":new Date(2016,7,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $112; previously $111.","showOnAxis":true},{"date":new Date(2016,8,7),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.6","showOnAxis":true},{"date":new Date(2016,9,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Financial Statements and Exhibits\r\n","showOnAxis":true},{"date":new Date(2016,9,27),"type":"sign","text":"K","backgroundColor":"#85CDE6","graph":"g1","description":"Release results of operational and financial condition\r\n","showOnAxis":true},{"date":new Date(2016,9,27),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CME reports 2016 Q3's earning $1.05 per share and revenue $841.7MM. This meets analyst's estimated EPS $1.05, misses estimated revenue $847.76MM.","showOnAxis":false},{"date":new Date(2016,9,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains CME to Buy. Target Price is $116; previously $115.","showOnAxis":true},{"date":new Date(2017,1,2),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, CME reports 2016 Q4's earning $1.14 per share and revenue $912.9MM. This beats analyst's estimated EPS $1.11, beats estimated revenue $903.79MM.","showOnAxis":false}];